Humoral and Cellular Immune Response to Elastin in Patients with Systemic Sclerosis

References

• Bruns M., Herrmann K., Haustein U. Immunologic parameters in systemic sclerosis. Int J Dermatol 1994; 33: 25–32
   PubMed Web of Science ®Google Scholar
• Kahan A., Picard F., Menkes C. J., Amor B. Abnormalities of T lymphocyte subjects in systemic sclerosis demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. Ann Rheum Dis 1991; 354–358
   PubMed Web of Science ®Google Scholar
• Gustafsson R., Totterman T. H., Klareskog L., Hall-Gren R. Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis 1990; 49: 40–45
   PubMed Web of Science ®Google Scholar
• Le Roy E. C. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis 1992; 51: 286–288
   PubMed Web of Science ®Google Scholar
• Huffstutter J. E., Dehustro F. A., Le Roy E. C. Cellular immunity to collagen and laminin in scleroderma. Arthritis Rheum 1985; 28: 775–780
   PubMed Web of Science ®Google Scholar
• Colburn C. C, Kelly G. T., Malto M. C, Sandberg L. B., Boucek R. J. Serum antitropo:anti-alpha-elastin antibody ratio assessing elastin turnover in scleroderma. Clin Rheumatol 1992; 11: 206–210
   PubMed Web of Science ®Google Scholar
• Kahaleh M. B., Sultany G. L., Smith E. A., Huffstutter J. E., Loadholt C. B., Le Roy E. C. A modified scleroderma skin scoring method. Clin Exp Rheumatol 1986; 4: 367–369
   PubMed Web of Science ®Google Scholar
• Le Roy E. C, Black C., Fleishmajer R., Jablonska S., Kriet T., Medsger T., Rowell N., Wollheim F. Scleroderma (Systemic sclerosis) classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–205
   PubMed Web of Science ®Google Scholar
• Baydanoff S., Nicoloff G., Gancheva Z., Chernov A., Kozhuharova M. Optimization of an enzyme method (ELISA) of discovering antibodies against elastin in human sera. Comp Rend Bulg Acad Sci 1986; 39: 89–91
   Google Scholar
• Needleman B. W. Immunologic aspects of scleroderma. Curr Opin Rheumatol 1992; 4: 862–868
   PubMedGoogle Scholar
• Kelly C. T., Colburn K. K., Malto M. C, Sandberg L. B., Boucek R. J. Sera elastin antibodies in assessing elastin turnover in scleroderma. Arthritis Rheum 1989; 32b: 159
   Google Scholar
• Scheja A., Akesson A., Horslev Petersen K. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis. Scand J Rheumatol 1992; 21: 5–9
   PubMed Web of Science ®Google Scholar
• Baydanoff S., Nicoloff G., Alexiev Ch. Age-dependent changes in the level of antielastin antibodies of different immunoglobulin classes (IgG, IgM, IgA and IgD) in the human serum. Cor Vasa 1991; 33: 197–205
   PubMedGoogle Scholar
• Baydanoff S., Nicoloff G., Alexiev Ch. Age-related changes in anti-elastin antibodies in serum from normal and atherosclerotic subjects. Atherosclerosis 1987; 63: 267–271
   PubMed Web of Science ®Google Scholar
• Hiketa T., Ohashi M., Matsumoto Y., Morikawa J., Sasaki R. Elevated serum immunoglobulin E levels in patients with juvenile dermatomyositis. J Allergy Clin Immunol 1992; 90: 405–407
   PubMed Web of Science ®Google Scholar
• Peter C., Hoting E., Bohm A. Humoral and cellular immunity in patients with alopecia areata: A study of 122 patients. Z Hautkr 1993; 68: 503–507
   Google Scholar
• Rehbun J., Quismorio F. J., Dubois E., Heiner D. C. Systemic lupus erythematosus activity and IgE. Ann Allergy 1983; 50: 34–36
   PubMedGoogle Scholar
• Degiannis D., Seibold J. R., Czarnecki M., Raskova J., Raska K. J. Soluble and cellular markers of immune activation in patients with systemic sclerosis. Clin Immunol lmmunopathol 1990; 56: 259–270
   PubMedGoogle Scholar
• Becker H., Langrock A., Federlin K. Imbalance of CD4(+) lymphocyte subsets in patients with mixed connective tissue disease. Clin Exp Immunol 1992; 88: 91–95
   PubMed Web of Science ®Google Scholar
• Al Janadi M., Raziuddin S. B cell hyperreactivity is a function of T cell derived cytokines in systemic lupus erythematosus. J Rheumatol 1993; 20: 1885–1891
   PubMed Web of Science ®Google Scholar
• Hawrylko E., Spertus A., Mele C. A., Oster N., Frieri M. Increased interleukin-2 production in response to human type I collagen stimulation in patients with systemic sclerosis. Arthritis Rheum 1991; 34: 580–587
   PubMed Web of Science ®Google Scholar
• DeCarli M., D'Elios M. M., Zancuoghi G., Romagnani S., Del Prete G. Human Th 1 and Th2 cells: Functional properties, regulation of development and role in autoimmunity. Autoimmunity 1994; 18: 301–308
   PubMed Web of Science ®Google Scholar
• Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227–257
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Sad S. The expanding universe of T-cell subsets: Thl, Th2 and more. Immunol Today 1996; 17: 138–146
   PubMedGoogle Scholar
• Liblau R. S., Singer S. M., McDevitt H. O. Th1 and Th2 CD4(+) T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16: 34–38
   PubMedGoogle Scholar
• Druet P., Sheela R., Pelletier L. Th1 and Th2 cells in autoimmunity. Clin Exp Immunol Suppl 1995; 101: 9–12
   PubMedGoogle Scholar
• Frieri M., Angadi C., Paolano A., Oster N., Blau S. P., Yang S., Mele C., Hawrylko E. Altered T cell subpopulations and lymphocytes expressing natural killer cell phenotypes in patients with progressive systemic sclerosis. J Allergy Clin Immunol 1991; 87: 773–779
   PubMed Web of Science ®Google Scholar
• Burns C. M., Tsai V., Zvaifler N. J. High percentage of CD8+ Leu-7+ cells in rheumatoid arthritis synovial fluid. Arthritis Rheum 1992; 35: 865–873
   PubMed Web of Science ®Google Scholar
• Kudlacek S., Jahandideh Kazempour S., Graninger W., Willvonseder R., Pietschmann P. Differential expression of various T cell surface markers in young and elderly subjects. Immunobiology 1995; 192: 198–204
   PubMed Web of Science ®Google Scholar
• Wang E. C. Y., Taylor Wiedeman J., Perera P, Fisher J., Borysiewicz L. K. Subsets of CD8(+), CD57(+) cells in normal, healthy individuals: Correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analysis. Clin Exp Immunol 1993; 94: 297–305
   PubMed Web of Science ®Google Scholar
• Prince H. E., Jensen E. R. Three-color cytoflu-orometric analysis of CD8 cell subsets in HIV-1 infection. J Acquired Immune Defic Syndr 1991; 4: 1227–1232
   PubMed Web of Science ®Google Scholar
• Baumert E., Wolff Vorbeck G., Schlesier M., Peter H. H. Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1992; 90: 25–30
   PubMed Web of Science ®Google Scholar
• Jaffe J. S., Eisenstein E., Sneller M. C, Strober W., Winkelstein Gelfand E.W., Levinson A., Frank, Shaef-Fer, Berger, Sorensen R. U., Wedgwood Boxer L., Schwartz. T-cell abnormalities in common variable immunodeficiency. Pediatr Res 1993; 33: S24–S28
   PubMed Web of Science ®Google Scholar
• Leroy E., Madariaga L., Aribia M. B., Mishal Z., Theo-Dorou I., Rochant H., Vernant J., Senik A. Abnormally expanded CD8(+)/Leu-(7+) lymphocytes persisting in long-term bone marrow-transplanted patients are resting pre-cytotoxic T-Iymphocytes. Exp Hematol 1990; 18: 770–774
   PubMed Web of Science ®Google Scholar
• D'Angeac A. D., Monier S., Jorgensen C., Gao Q., Tra-Vaglio Encinoza A., Bologna C., Combe B., Sany J., Reme T. Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis: Correlation with duration of disease. Arthritis Rheum 1993; 36: 608–612
   PubMed Web of Science ®Google Scholar
• D'Angeac A. D., Monier S., Pilling D., Travaglio Encinoza A., Reme T., Salmon M. CD57(+) T lymphocytes are derived from CD57(-) precursors by differentiation occurring in late immune responses. Eur J Immunol 1994; 24: 1503–1511
   PubMed Web of Science ®Google Scholar
• Morley J. K., Batliwalla F. M., Hingorani R., Greger-Sen P. K. Oligoclonal CD8(+) T cells are preferentially expanded in the CD57(+) subset. J Immunol 1995; 554: 6182–6190
   Google Scholar
• Yamashita N., Nguyen L., Fahey J. L., Clement L. T. Phenotypic properties and cytotoxic functions of human CD8+cells expressing the CD57 antigen. Nat Immun 1993; 12: 79–91
   PubMedGoogle Scholar
• Sadat Sowti B., Debre P., Idziorek T., Guillon J., Hadida F., Okzenhendler E., Katlama C., Mayaud C., Autran B. A lectin-binding soluble factor released by CD8(+)CD57(+) lymphocytes from AIDS patients inhibits T cell cytotoxicity. Eur J Immunol 1991; 21: 737–741
   PubMed Web of Science ®Google Scholar